Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Children's Oncology Group
Children's Oncology Group
St. Jude Children's Research Hospital
City of Hope Medical Center
Medical College of Wisconsin
Dartmouth-Hitchcock Medical Center
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
St. Jude Children's Research Hospital
BTG International Inc.
South Plains Oncology Consortium
Milton S. Hershey Medical Center
National Institutes of Health Clinical Center (CC)
Takeda
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Massachusetts General Hospital
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northside Hospital, Inc.
Centre Henri Becquerel